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Identity 
Hugo: KLF6 
Other names: BCD1; COPEB (Core promoter binding 
protein); CPBP; GBF; PAC1; ST12; Zf9 
Location: 10p15.1 
DNA/RNA 
Description 
Spans 11 kb; five exons; 4 CDS exons. 
Transcription 
Full length transcript of 4.1 kb, open reading frame 849 
bp. There are at least three alternative splice transcripts. 
Protein 
Description 
Full length transcript encodes a 283 amino acids 
protein, 42 kDa, with a 201 amino acids transactivation 
domain and an 82 amino acids DNA binding domain 
with 3 C2H2 zinc fingers. There is at least one putative 
nuclear localization signal immediately 5' to the DNA 
binding domain. 
There are at least three alternative splice transcript  
encoding proteins of 195 (KLF6-SV1), 237 (KLF6-
SV3), and 241 amino acids (KLF6-SV2). 
Several post-translational modifications including 
phosphorylation, ubiquitinylation, acetylation are 
suggested based on encoded protein sequence motifs. 
Expression 
Ubiquitously expressed in adult tissues, restricted 
during embryogenesis but includes placenta, neural and 
non-neural tissues, and cornea. Full-length KLF6 
downregulated in many human cancers (see below). 
Expression pattern of KLF6 splice variants may be 
upregulated. 
Localisation 
Found in both nucleus and cytoplasm, but 
predominantly nuclear. Splice variants SV1 and SV2 
primarily cytoplasmic and believed to be the result of 
loss of nuclear localization signal (NLS). Splice variant 
3 retains the NLS. 
Function 
Tumor suppressor gene, immediate early gene in tissue 
injury and fibrosis, during adenoviral and pseudomonas 
infections and during ischemic reperfusion in kidney. 
Transactivator of multiple target genes including p21, 
TGFbeta1, TGFbeta receptors type II and TGFbeta 
receptors type III, human keratin 4 and 12 genes: 
inducible nitric oxide synthase, endoglin, insulin-like 
growth factor receptor 1, multi-drug resistance 
transporters, E-cadherin, leukotriene C(4)(LTC4S), 
laminin 111, acid ceramidase, alpha 1 proteinase 
inhibitor. 
Suppresses growth by inducing p21, sequestering 
cyclin D1 and/or inhibiting c-jun oncogene. 
Promotes differentiation of preadipocytes to adipocytes 
in culture and hepatocytes in vivo. 
Contributes to fetal development of mouse cornea and 
lens; and immune and hematopoietic systems by 
contributing to hemangioblast phenotype. 
Interacts with the core promoter element of a TATA 
box-less gene. 
Induces apoptosis of lung cancer cells. 
Homology 
The 47 N-terminal amino acids are identical to KLF7, 
and the 82 amino acids DNA binding domain highly 
homologous to other members of the KLF family. Also 
homologous to the Drosophila Luna gene. 
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Mutations 
Germinal 
None identified to date. However, a germline single 
nucleotide intronic polymorphism (IVS1-27 G > A) has 
been identified that creates a novel SRp40 DNA 
binding site, therby increasing the generation of three 
alternatively spliced mRNAs, and which is associated 
with an increased risk of prostate cancer. Other low
frequency coding and non-coding SNPs have been 
identified. 
Somatic 
A number of somatic mutations were originally 
identified in prostate cancer and shown to result in oss 
of function. These include Trp64Arg, Ser116Pro, 
Ala123Asp and Ser137X. 
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